|
|
| | OMAPATRILAT Basic information |
| Product Name: | OMAPATRILAT | | Synonyms: | OMAPATRILAT;VANLEV;OMAPATRILAT/VANLEV;BMS 186716-01;7H-Pyrido[2,1-b][1,3]thiazepine-7-carboxylic acid, octahydro-4-[[(2S)-2-mercapto-1-oxo-3-phenylpropyl]amino]-5-oxo-, (4S,7S,10aS)-;Omapatrilat >=98% (HPLC);Omapatrilat (BMS-186716) | | CAS: | 167305-00-2 | | MF: | C19H24N2O4S2 | | MW: | 408.53 | | EINECS: | | | Product Categories: | | | Mol File: | 167305-00-2.mol |  |
| | OMAPATRILAT Chemical Properties |
| Melting point | 218-220° | | alpha | D -78.9° (c = 0.46 in DMF) | | Boiling point | 724.2±60.0 °C(Predicted) | | density | 1.37±0.1 g/cm3(Predicted) | | storage temp. | under inert gas (nitrogen or Argon) at 2-8°C | | solubility | DMSO: 30 mg/ml | | form | A crystalline solid | | pka | 3.44±0.40(Predicted) | | color | White to gray |
| | OMAPATRILAT Usage And Synthesis |
| Uses | Treatment of hypertension and congestive heart failure (neutral endopeptidase and angiotensin converting enzyme inhibitor). | | Definition | ChEBI: Omapatrilat is a dipeptide. |
| | OMAPATRILAT Preparation Products And Raw materials |
|